摘要
采用聚合酶链反应检测114例肝病患者血清HBV-DNA。结果:114例患者血清HBV-DNA阳性率35.96%,其中AH、CPH、CAN、LC组HBV-DNA阳性率分别为41.67%、21.43%、53.66%和26.31%;HBeAg(+)组39.02%,抗HBc(+)组22.73%,HBsAg(+)、抗HBc(+)组43.37%,抗HBs(+)组41.18%;HBVM(-)组11.11%。结果提示:①CAH组阳性率较高(53.66%);②抗HBe(+)患者血清中有高滴度HBV-DNA,提示仍有传染性;③抗HBe(+)、抗HBs(+)、HBVM(-)的患者HBV-DNA阳性可能为HBV的变异株感染。
The serum HBV-DNA were determined by polymerase chain reaction(PCR)in 114 cases of hepatic diseases , the positivity rate of serum HBV-DNA being35.96%.The positivity rates in the AH,CPH,CAH and LC group were 41.7%,21.42%,53.66%and 26.84%respsctively.the posivity rate was 39.02%in the HBeAg(+)group,22.73%in the anti-HBe(+)group,47.37%in the HBsAg(+)and anti-HBc(+)group,41.18%in the anti+HBs(+)group, and 11. 11%in the HBVM(-)group.Theresults reveal that the posivity rate of serum HBV-DNA in the CAH group is the highest(53.66%)in the clinical type groups;there is high titer HBV-DNA in serum ot anti-HBe(+)group,suggesting that tne infectivity exists yet;patients in the anti-HBe(+),anti-HBs(+)and HBVM(-)group whose serum HBV-DNA test is positive may be infected byvariant HBV.
出处
《承德医学院学报》
1996年第4期273-275,共3页
Journal of Chengde Medical University